2021 COSO 肿瘤治疗相关心血管毒性防治指南

2021-08-01 中国临床肿瘤学会 人民卫生出版社

2021年8月,中国临床肿瘤学会发布《2021CSCO肿瘤治疗相关心血管毒性防治指南》。

中文标题:

2021 COSO 肿瘤治疗相关心血管毒性防治指南

发布机构:

中国临床肿瘤学会

发布日期:

2021-08-01

简要介绍:

2021年8月,中国临床肿瘤学会发布《2021CSCO肿瘤治疗相关心血管毒性防治指南》。指南共分为《概述》、《抗肿瘤药物心血管毒性诊疗总则》、《抗肿瘤药物心血管毒性的一级预防》、《抗肿瘤药物心血管毒性的监测》、《无症状心血管毒性的处理原则》、《症状性心血管毒性的处理原则》、《特殊人群的心血管毒性处理原则》、《癌症幸存者的康复护理和随访》八大部分。

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2107707, encodeId=93ce210e70778, content=扣了分没下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fb5568365, createdName=喇叭提交, createdTime=Tue Dec 27 19:45:34 CST 2022, time=2022-12-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1197517, encodeId=77fe119e5174c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Sat Feb 26 16:27:08 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182740, encodeId=077d1182e40d8, content=可以重发一下吗,医院不存在, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/08171BBB505F8EC6D2347D98CD856865/100, createdBy=a92a2396540, createdName=喻伊森, createdTime=Mon Jan 10 09:17:55 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181715, encodeId=bc8c1181e151c, content=资源不存在。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92106452483, createdName=ms8000000212870948, createdTime=Fri Jan 07 08:27:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085798, encodeId=616b1085e9866, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:56:48 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-12-27 喇叭提交 来自河北省

    扣了分没下载

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2107707, encodeId=93ce210e70778, content=扣了分没下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fb5568365, createdName=喇叭提交, createdTime=Tue Dec 27 19:45:34 CST 2022, time=2022-12-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1197517, encodeId=77fe119e5174c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Sat Feb 26 16:27:08 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182740, encodeId=077d1182e40d8, content=可以重发一下吗,医院不存在, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/08171BBB505F8EC6D2347D98CD856865/100, createdBy=a92a2396540, createdName=喻伊森, createdTime=Mon Jan 10 09:17:55 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181715, encodeId=bc8c1181e151c, content=资源不存在。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92106452483, createdName=ms8000000212870948, createdTime=Fri Jan 07 08:27:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085798, encodeId=616b1085e9866, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:56:48 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-02-26 ms9000000046672090

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2107707, encodeId=93ce210e70778, content=扣了分没下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fb5568365, createdName=喇叭提交, createdTime=Tue Dec 27 19:45:34 CST 2022, time=2022-12-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1197517, encodeId=77fe119e5174c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Sat Feb 26 16:27:08 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182740, encodeId=077d1182e40d8, content=可以重发一下吗,医院不存在, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/08171BBB505F8EC6D2347D98CD856865/100, createdBy=a92a2396540, createdName=喻伊森, createdTime=Mon Jan 10 09:17:55 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181715, encodeId=bc8c1181e151c, content=资源不存在。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92106452483, createdName=ms8000000212870948, createdTime=Fri Jan 07 08:27:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085798, encodeId=616b1085e9866, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:56:48 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-01-10 喻伊森

    可以重发一下吗,医院不存在

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2107707, encodeId=93ce210e70778, content=扣了分没下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fb5568365, createdName=喇叭提交, createdTime=Tue Dec 27 19:45:34 CST 2022, time=2022-12-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1197517, encodeId=77fe119e5174c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Sat Feb 26 16:27:08 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182740, encodeId=077d1182e40d8, content=可以重发一下吗,医院不存在, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/08171BBB505F8EC6D2347D98CD856865/100, createdBy=a92a2396540, createdName=喻伊森, createdTime=Mon Jan 10 09:17:55 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181715, encodeId=bc8c1181e151c, content=资源不存在。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92106452483, createdName=ms8000000212870948, createdTime=Fri Jan 07 08:27:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085798, encodeId=616b1085e9866, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:56:48 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2022-01-07 ms8000000212870948

    资源不存在。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2107707, encodeId=93ce210e70778, content=扣了分没下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fb5568365, createdName=喇叭提交, createdTime=Tue Dec 27 19:45:34 CST 2022, time=2022-12-27, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1197517, encodeId=77fe119e5174c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Sat Feb 26 16:27:08 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182740, encodeId=077d1182e40d8, content=可以重发一下吗,医院不存在, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/08171BBB505F8EC6D2347D98CD856865/100, createdBy=a92a2396540, createdName=喻伊森, createdTime=Mon Jan 10 09:17:55 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181715, encodeId=bc8c1181e151c, content=资源不存在。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92106452483, createdName=ms8000000212870948, createdTime=Fri Jan 07 08:27:45 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085798, encodeId=616b1085e9866, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98ad6192838, createdName=66304_9712, createdTime=Thu Dec 30 12:56:48 CST 2021, time=2021-12-30, status=1, ipAttribution=)]
    2021-12-30 66304_9712

    学习学习

    0

拓展阅读

2014 ESMO 肿瘤患者骨健康临床实践指南

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2014-04-29

2014 嗜铬细胞瘤和副神经节瘤:内分泌学会临床实践指南

美国内分泌学会(TES,The Endocrine Society) · 2014-06-07

2014 BC指南:女性生殖系统肿瘤-子宫内膜癌

英国哥伦比亚临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2014-06-15

2014 加拿大专家共识:胰腺神经内分泌肿瘤的诊断和管理

国外肿瘤科相关专家小组(统称) · 2014-11-04

2014 ACMG/NSGC实践指南:转诊肿瘤易感性评估

美国医学遗传学与基因组学学会(ACMG,American College of Medical Genetics and Genomics) · 2014-11-13

2015 ACG临床指南:遗传性胃肠道肿瘤综合征的管理和基因检测

美国胃肠病学院(ACG,American College of Gastroenterology) · 2015-02-03